% Expired Patents = 60.0

Forward Citations = 9

Loading Chart...

7 inventors (with patents filed for the assignee):

Neil Andrew Williams (5 out of 6 patents)

Timothy Raymond Hirst (5 out of 6 patents)

John Bienenstock (3 out of 9 patents)

4. Andrew Morgan (1 out of 1 patent)

5. Andrew Douglas Wilson (1 out of 1 patent)

6. Lucy Amber Bird (1 out of 1 patent)

7. Toufic Osman Nashar (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 8992940 - Agent for treating allergic or hypersensitivity condition (2015-03-31),

2. 8357372 - Agent for treating allergic or hypersensitivity condition (2013-01-22),

3. 7914791 - Vaccine (2011-03-29),

4. 7588763 - Methods for the prevention against or treatment of diabetes with ETXB and/or insulin (2009-09-15),

5. 7208155 - Agent for treating allergic or hypersensitivity condition (2007-04-24),

Company Overview

Trident Pharmaceuticals, Inc. is a leading pharmaceutical company that specializes in the research, development, and commercialization of innovative drugs. With a focus on improving patient outcomes and quality of life, Trident Pharmaceuticals strives to bring cutting-edge therapies to market. Our dedicated team of scientists, researchers, and healthcare professionals work tirelessly to address unmet medical needs and make a positive impact on global health. Visit our website to learn more about our products and pipeline.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#299 in Boston, MA

#2,894 in Massachusetts

#51,620 in US

Boston, MA, United States of America

Trident Pharmaceuticals, Inc.

Forward Citations = 9

7 inventors:

Neil Andrew Williams (5 out of 6 patents)

Timothy Raymond Hirst (5 out of 6 patents)

John Bienenstock (3 out of 9 patents)

4. Andrew Morgan (1 out of 1 patent)

5. Andrew Douglas Wilson (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Trident Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/trident-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]